| Varsani Pharmacy Limited |
| Registered number: |
11990057 |
| Balance Sheet |
| as at 31 May 2025 |
|
| Notes |
|
|
2025 |
|
|
2024 |
| £ |
£ |
| Fixed assets |
| Intangible assets |
3 |
|
|
330,000 |
|
|
352,000 |
| Tangible assets |
4 |
|
|
3,096 |
|
|
3,685 |
| Investments |
5 |
|
|
900,845 |
|
|
900,845 |
|
|
|
|
1,233,941 |
|
|
1,256,530 |
|
| Current assets |
| Stocks |
|
|
50,750 |
|
|
49,550 |
| Debtors |
6 |
|
82,075 |
|
|
34,033 |
| Cash at bank and in hand |
|
|
64,538 |
|
|
59,889 |
|
|
|
197,363 |
|
|
143,472 |
|
| Creditors: amounts falling due within one year |
7 |
|
(116,961) |
|
|
(149,354) |
|
| Net current assets/(liabilities) |
|
|
|
80,402 |
|
|
(5,882) |
|
| Total assets less current liabilities |
|
|
|
1,314,343 |
|
|
1,250,648 |
|
| Creditors: amounts falling due after more than one year |
8 |
|
|
(1,073,217) |
|
|
(1,119,693) |
|
| Net assets |
|
|
|
241,126 |
|
|
130,955 |
|
|
|
|
|
|
|
|
| Capital and reserves |
| Called up share capital |
|
|
|
100 |
|
|
100 |
| Profit and loss account |
|
|
|
241,026 |
|
|
130,855 |
|
| Shareholders' funds |
|
|
|
241,126 |
|
|
130,955 |
|
|
|
|
|
|
|
|
| The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006. |
| The members have not required the company to obtain an audit in accordance with section 476 of the Act. |
| The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. |
| The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. |
|
|
|
| J Varsani |
| Director |
| Approved by the board on 6 November 2025 |
|
| Varsani Pharmacy Limited |
| Notes to the Accounts |
| for the year ended 31 May 2025 |
|
|
| 1 |
Accounting policies |
|
|
Turnover |
|
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. |
|
|
Intangible fixed assets |
|
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses. |
|
|
Tangible fixed assets |
|
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows: |
|
|
Plant and machinery |
25% reducing balance |
|
Fixtures, fittings, tools and equipment |
25% reducing balance |
|
|
Investments |
|
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account. |
|
|
Stocks |
|
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised. |
|
|
Debtors |
|
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts. |
|
|
Creditors |
|
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. |
|
|
Taxation |
|
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. |
|
|
| 2 |
Employees |
2025 |
|
2024 |
| Number |
Number |
|
|
Average number of persons employed by the company |
7 |
|
6 |
|
|
|
|
|
|
|
|
|
|
| 3 |
Intangible fixed assets |
£ |
|
Goodwill: |
|
|
Cost |
|
At 1 June 2024 |
440,000 |
|
At 31 May 2025 |
440,000 |
|
|
|
|
|
|
|
|
|
|
Amortisation |
|
At 1 June 2024 |
88,000 |
|
Provided during the year |
22,000 |
|
At 31 May 2025 |
110,000 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 31 May 2025 |
330,000 |
|
At 31 May 2024 |
352,000 |
|
|
|
|
|
|
|
|
|
|
Goodwill is being written off in equal annual instalments over its estimated economic life of 20 years. |
|
|
| 4 |
Tangible fixed assets |
|
|
|
|
|
|
|
|
Plant and machinery etc |
| £ |
|
Cost |
|
At 1 June 2024 |
9,062 |
|
Additions |
443 |
|
At 31 May 2025 |
9,505 |
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
At 1 June 2024 |
5,377 |
|
Charge for the year |
1,032 |
|
At 31 May 2025 |
6,409 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 31 May 2025 |
3,096 |
|
At 31 May 2024 |
3,685 |
|
|
| 5 |
Investments |
| Investments in |
| subsidiary |
| undertakings |
| £ |
|
Cost |
|
At 1 June 2024 |
900,845 |
|
|
At 31 May 2025 |
900,845 |
|
|
| 6 |
Debtors |
2025 |
|
2024 |
| £ |
£ |
|
|
Trade debtors |
3,226 |
|
5,326 |
|
Amounts owed by group undertakings and undertakings in which the company has a participating interest |
|
50,000 |
|
- |
|
Other debtors |
28,849 |
|
28,707 |
|
|
|
|
|
|
82,075 |
|
34,033 |
|
|
|
|
|
|
|
|
|
|
| 7 |
Creditors: amounts falling due within one year |
2025 |
|
2024 |
| £ |
£ |
|
|
Trade creditors |
3,640 |
|
5,390 |
|
Taxation and social security costs |
20,674 |
|
1,467 |
|
Other creditors |
92,647 |
|
142,497 |
|
|
|
|
|
|
116,961 |
|
149,354 |
|
|
|
|
|
|
|
|
|
|
| 8 |
Creditors: amounts falling due after one year |
2025 |
|
2024 |
| £ |
£ |
|
|
Bank loans |
1,073,217 |
|
1,119,693 |
|
|
|
|
|
|
|
|
|
|
| 9 |
Other information |
|
|
Varsani Pharmacy Limited is a private company limited by shares and incorporated in England. Its registered office is: |
|
12 Daventer Drive |
|
Stanmore |
|
Middlesex |
|
HA7 3TJ |